Propeller Health Raises Strategic Investment from McKesson Ventures
Propeller Health announced today that McKesson Ventures has contributed an undisclosed amount to its $20 million strategic funding round. The funding will allow Propeller Health to continue developing connected medicines for the treatment of chronic respiratory disease and expand into additional therapeutic areas. David Van Sickle, co-founder and CEO of Propeller Health commented on the impact of the investment on the company’s current and future initiatives. “We’ve accumulated the expertise, infrastructure and distribution network to put connected medicines in the hands of people around the world,”...